Skip to main content
Premium Trial:

Request an Annual Quote

Kevin Harley, Tim Orpin, Richard Shen

Illumina announced a number of personnel changes during its third-quarter conference call last week.
 
Kevin Harley has joined the firm as vice president of human resources. He previously held a similar position at Intralase. Before Intralase, Harley worked at Edwards Lifesciences and Baxter Healthcare, Illumina said.
 
Tim Orpin has also joined the company as general manager of Asia Pacific and Japan. Orpin served previously as vice president, Asia Pacific, for Applied Biosystems.
 

Additionally, Illumina said that Richard Shen has been promoted to vice president of assay biochemistry and reagent manufacturing. He previously served as senior director of array biochemistry.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.